Health Sector/Insurance

Written by Allison DeAngelis

One of the Boston area’s biotech giants is spending close to $1 billion to acquire a Pennsylvania startup developing a companion to its cornerstone product.

Alexion (Nasdaq: ALXN) announced Wednesday that it will acquire clinical-stage startup Achillion Pharmaceuticals Inc. (Nasdaq: …

CAMBRIDGE, Mass., Oct. 8, 2019 /PRNewswire/ — Flagship Pioneering, a unique life sciences innovation enterprise, today unveiled Cygnal Therapeutics. Founded in 2017 in Flagship Labs, Flagship’s innovation foundry, Cygnal is the first company to develop drugs in the field of …

Written by Gina Kolata.

A new drug, created to treat just one patient, has pushed the bounds of personalized medicine and has raised unexplored regulatory and ethical questions, scientists reported Wednesday.

The drug, described in the New England Journal of …

Written by Allison DeAngelis

Mere months after raising $135 million from investors, another gene editing startup co-founded by MIT researcher Feng Zhang is preparing to go public.

Cambridge’s Beam Therapeutics filed documents with the SEC after markets closed Friday disclosing …

Written by Ralph Orlowski

BioNtech SE, Europe’s largest unlisted biotech firm by staff numbers, said on Tuesday that it planned to raise up to $303.6 million in an initial public offering in the United States.

The company expects its offering …